News Results

There are 684,310 News Results

Dec 12, 2017
Global OTC Braces & Support Market to 2022: Ligament Injury Segment to Dominate the OTC Orthopedic Braces and Supports Market as of 2017
DUBLIN, Dec. 13, 2017 /PRNewswire/ -- The "OTC Braces & Support Market by Product, Application, Sales Channel - Global Forecasts to 2022" report has been added to
Jan 18, 2018
Independent Imaging Review Confirmed Positive Data from Primary Analysis of REFLECT Trial Evaluating Lenvatinib Compared to Sorafenib in Unresectable Hepatocellular Carcinoma
WOODCLIFF LAKE, N.J., Jan. 19, 2018 /PRNewswire/ -- Eisai Inc. announced today results from the independent imaging review (IIR) of the REFLECT study (Study 304), a Phase 3 trial evaluating...
Jan 24, 2018
New Construction Starts in December Rebound 12 Percent; Annual Total for 2017 Advances 3 Percent to $745.9 Billion
NEW YORK, Jan. 25, 2018 /PRNewswire/ -- New construction starts in December climbed 12% to a seasonally adjusted annual rate of $733.3 billion, bouncing back following November's 12% decline, according...
Mar 8, 2018
Scientists honored with Kappa Delta awards for advancing orthopaedic research
Scientists honored with Kappa Delta awards for advancing orthopaedic research
May 15, 2018
Merck KGaA, Darmstadt, Germany Data at ASCO 2018 to Showcase Progress and Further Optionality of Oncology Pipeline
Merck KGaA, Darmstadt, Germany Data at ASCO 2018 to Showcase Progress and Further Optionality of Oncology Pipeline
May 16, 2018
Eisai Announces Data at ASCO 2018 Annual Meeting Showcasing LENVIMA® (lenvatinib) and KEYTRUDA® (pembrolizumab) Combination Therapy Under Strategic Oncology Collaboration with Merck
Eisai Announces Data at ASCO 2018 Annual Meeting Showcasing LENVIMA® (lenvatinib) and KEYTRUDA® (pembrolizumab) Combination Therapy Under Strategic Oncology Collaboration with Merck
Jun 11, 2018
Global LAN/WAN Test Equipment Industry
LONDON, June 11, 2018 /PRNewswire/ --
Jul 24, 2018
Janssen Presents Switch Data for New HIV-1 Treatment SYMTUZA(TM) (D/C/F/TAF) and Second Study Supporting its Use in a Rapid Initiation Scenario
AMSTERDAM, July 24, 2018 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data reinforcing the safety and efficacy of switching to SYMTUZA(TM) (D/C/F/TAF) for the...
Aug 1, 2018
Parkinson's Disease Market 2018 by Phase of Development, Type of Treatment, Type of Molecule, Mechanism of Action, Route of Administration, and Leading Players
DUBLIN, Aug. 1, 2018 /PRNewswire/ -- The "Parkinson's Disease Market: Pipeline Review, Developer Landscape and Competitive Insights" report has been added to
Jun 2, 2017
Further Study of Combination of Eisai's Lenvatinib and Merck's Pembrolizumab in Previously Treated Patients with Metastatic Endometrial Cancer Supported by Interim Analysis of Ongoing Phase 1b/2 Trial
WOODCLIFF LAKE, N.J., June 3, 2017 /PRNewswire/ -- Eisai Inc. today announced interim results from the first evaluable cohort of Study 111, a Phase 1b/2 study investigating lenvatinib (marketed as...
68431

Pages

1

Stories of the day

Sep 12, 2025
DSEI 2025: Boxer – Rheinmetall increases capacity in Telford – with an eye on...
Sep 12, 2025
GA-ASI and AeroVironment Complete First-Ever Air Launch of Switchblade 600 from...
Sep 12, 2025
MBDA unveils STRATUS for future cruise and anti-ship capabilities
Sep 12, 2025
L3Harris Providing EO/IR targeting systems to Kongsberg Defence and Aerospace...